Attached files
Exhibit 10.3
THIRD ADDENDUM TO EXCLUSIVE LICENSE AGREEMENT
This THIRD ADDENDUM TO EXCLUSIVE LICENSE AGREEMENT
(this “First Amendment”)
is made as of the 11th day of May, 2020, by and between Marv
Enterprises, LLC a Limited Liability Company organized and existing
under the laws of the Commonwealth of Pennsylvania
(“Marv”)
with an address of P.O. Box 1332, Hermitage, PA 16148 and Premier
Biomedical, Inc.., a Nevada corporation with its principal business
address at 1362 Springfield Church Road, Jackson Center, PA 16133
(“Licensee”).
WHEREAS,
Marv and Licensee have previously entered into an Exclusive License
Agreement with effective date of May 12, 2010;
WHEREAS
Marv and Licensee have previously entered into a First Addendum on
August 17, 2011;
WHEREAS
Marv and Licensee have previously entered into a Second Addendum on
December 27, 2011; and
WHEREAS,
the parties wish to further amend the Agreement as set forth herein
to be consistent with the actions of the parties since the
effective date of the Exclusive License Agreement up to an
including the effective date of this Third Addendum.
NOW,
THEREFORE, in consideration of the foregoing and for good and
valuable consideration, the receipt and sufficiency which are
hereby acknowledged, the parties hereby agree as
follows:
That
under the Second Addendum 1.(i) and (ii), the Applications listed
in Appendix A current as of the effective date of this agreement,
are not refused by Premier and that Premier will pay Marv for
expenses of all patent work. And that under 1. (iii), Premier will
be the exclusive licensee under and as part of the Original
Agreement.
IN
WITNESS WHEREOF, the parties have executed this First Amendment as
of the date first written above.
| LICENSEE | LICENSOR |
|
||
|
By
 5/11/2020 |
|
|
|
|
| William Hartman |
|
|
Mitchell S.
Felder
|
|
|
CEO and President
of Premier Biomedical,
Inc.
|
|
|
Marv Enterprises, LLC |
|